Ebola Bundibugyo Virus Disease Outbreak – Democratic Republic of the Congo
As of June 2026, the Democratic Republic of the Congo (DRC) is experiencing an active outbreak of Bundibugyo virus disease (BVD) in three eastern provinces: Ituri, Nord-Kivu (North Kivu), and Sud-Kivu (South Kivu). The CDC has issued a Level 3 Travel Advisory, recommending that travelers avoid all nonessential travel to these affected regions.
About Bundibugyo Virus Disease
Bundibugyo virus is a species of Ebola virus that causes severe, often fatal illness. BVD is spread through direct contact with blood or body fluids of infected individuals, or with surfaces contaminated by these fluids. Healthcare workers and family members caring for patients face elevated exposure risk. The virus does not spread through the air, water, or food.
Key Precautions for Travelers
- Avoid affected provinces (Ituri, Nord-Kivu, Sud-Kivu) unless travel is essential
- Maintain strict hygiene: frequent handwashing with soap and water
- Avoid contact with blood, body fluids, and potentially infected persons
- Do not handle animals, particularly fruit bats, primates, and forest antelope, which may carry the virus
- Seek immediate medical attention if symptoms develop (fever, headache, muscle pain, weakness, diarrhea, vomiting, rash, impaired kidney/liver function) within 2–21 days of potential exposure
Medical Considerations
There is no specific vaccine for Bundibugyo virus. However, the rVSV-ZEBOV vaccine (for Zaire Ebola virus) may provide cross-protective benefit and may be considered for high-risk travelers in consultation with a travel medicine provider. Standard infection prevention measures—personal protective equipment, isolation protocols, safe burial practices—are critical in healthcare and community settings.
Travel Recommendations
Essential travelers to other regions of the DRC should:
- Register with their embassy
- Maintain comprehensive travel health insurance with medical evacuation coverage
- Identify reliable healthcare facilities in advance
- Consult a travel medicine clinic 4–6 weeks before departure
Pharmacist's Note: While no pharmacological prophylaxis exists for BVD, travelers should ensure routine immunizations are current (e.g., yellow fever, hepatitis A/B, typhoid, polio) and carry a well-stocked travel medical kit. If fever or relevant symptoms develop during or after travel, seek medical evaluation immediately and inform providers of potential Ebola exposure. Antiviral drugs are under investigation; supportive care remains the standard management approach.
For the latest updates, consult the CDC travel advisory website and your national health authority.